Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the must-buy penny stocks to invest in now. Recursion Pharmaceuticals ...
COLUMBIA, Md., April 20, 2026 — Advarra, the market leader in IRB oversight and a leading provider of connected, intelligence-powered research technology, today announced the release of a new ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
Opinion
6hOpinion
To be human is to live with friction. That’s something AI boosters will never understand
We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...
With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
5dOpinion
AI needs a reality check
You can bring initial model predictions closer to reality by training those AI models on rich patient data. The more detailed ...
AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...
In a first-of-its-kind finding, researchers at University of Iowa Health Care discovered that specific genetic sequences have ...
There are always too many standards to meet and assignments to grade. These strategies can help you reject haste in favor of ...
Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious ...
OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...
The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results